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Peripheral blood mononuclear cells (PBMCs) can respond to dietary stimuli modulating
the up-regulation of pro-inflammatory cell signaling, which is associated with metabolic
disease and has been seen to be elevated in African American (AA) when compared to
Caucasian American (CA) women. Little is known about the response of PBMCs to a
high fat meal among women and the potential impact of ethnicity and/or weight status on
this response. The purpose of this study was to examine PBMC response to consuming a
high fat meal and the response to culturing PBMCs in media supplemented with lipid
among AA and CA women, and to determine the impact that ethnicity and/or weight
status may have on this response. Twenty-one women participated in the study: 10 AA
(age: 28.00±6.60), 11 CA (age: 26.91±6.28), of whom 11 were lean (BMI<27.0) and 9
were obese (BMI≥27.0). PBMCs were isolated at baseline (pre-shake) and 4-hours post
high-fat shake ingestion then cultured for 3 hours in 1) RPMI-1640 media (control) or 2)
RPMI-1640 media supplemented with 250uM 1:1 Oleate: Palmitate (lipid-treated);
resulting in the following experimental conditions: 1) pre-shake, control; 2) pre-shake,
lipid-treated; 3) post-shake, control; and 4) post-shake, lipid-treated. Using RT-PCR, we
evaluated gene expression of IL-6, IL-8, IL-10, and TNF-. Repeated-measures ANOVA
were performed with emphasis on a time (pre- vs. post-shake) X treatment (control vs.
lipid-treated culture) X ethnicity or weight status interactions. PBMC IL-8 gene
expression significantly increased post-shake in both the control (p=0.05) and lipid-

vii

treated (p=0.01) conditions for all subjects. In the post-shake, control condition IL-8 gene
expression was significantly higher among the AA women (p=0.03). Among the AA
women there was a significant decrease in IL-6 gene expression post-shake in the lipidtreated condition (p=0.04). The expression of IL-6 and IL-8 significantly decreased in the
lipid (p<0.05) condition in obese women, post-shake. The expression of IL-8
significantly increased in both the control (p=0.04) and lipid (p=0.05) conditions in lean
women, post-shake. This study showed that the ingestion of a high fat shake does effect
PBMC gene expression response in women with specific gene expression differences
noted between different ethnicities and weight statuses.

viii

Chapter 1. Introduction
The immune system plays a vital role in the prevention and development of many
diseases, including cardiovascular and metabolic disease (Drew, 2012). The control of the
immune system and other cellular defense systems (e.g. metabolism) are interlinked and
require a network of communication between immune cells to direct defense and respond
to environment (Drew, 2012). These systems are highly responsive to an acute dietary
intake, such as a meal in a typical Western high fat diet, which can modulate a variety of
physiological processes (Drew, 2012), such as the upregulation of pro-inflammatory cell
signaling (Monterio & Azevedo, 2010). An essential step in the maturation of immune
cells is the reprograming of their metabolic profiles as a result of an extracellular stimuli
(Ganeshan & Chawla, 2014), which can be a representation of a whole body systemic
response.
Peripheral blood mononuclear cells (PBMCs) collectively refer to a
heterogeneous mixture of mononuclear immune cells (Koncarevic et al., 2014) that are an
imperative component of the immune system (Arosio et al., 2014). In recent years, the
investigation of how PBMCs, as a representor of systemic immune response, are related
to metabolic biomarkers and disease has ensued (Bouwens et al., 2010; Stepien et al.,
2014) in relation to the unique gene expression seen in PBMCs from patients with
systemic inflammatory diseases (Aune, Maas, Parker, Moore, & Olsen, 2004; Edwards et
al., 2007; Mandal, Gurevich, Pauzner, Kaminski, & Achiron, 2004; van ‘t Veer et al.,
2002). The investigation of PBMCs could serve as a model to investigate the link
between immune function, inflammation, and metabolic disease. The inflammatory state
of circulating PBMCs elicits alterations to their gene expression, affecting other cellular
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function (Aune et al., 2004; Edwards et al., 2007; Mandal et al., 2004; O’Rourke et al.,
2006; van ‘t Veer et al., 2002). Cytokines can be produced and released by peripheral
blood mononuclear cells (Friberg et al., 1994) and in an obese population can play a role
in insulin resistance (Rodriguez-Hernandez et al., 2013).
The predominance of cardiovascular disease risk, obesity, high cholesterol, and
hypertension is increased among African American (AA) women compared to Caucasian
American (CA) women (Malayala & Raza, 2016). African Americans also have
increased insulin resistance when compared to CAs (Meis, Schuster, Gaillard, & Osei,
2006), which is a direct indication that the action of insulin at the tissue level is impaired
(Kasim-Karakas, 2000). Additionally, AAs have a disproportionately higher coronary
heart disease mortality and morbidity rate (Clark et al., 2001).
With an increase in disease risk among AA women (Taylor et al., 2008) the
likelihood of an elevated pro-inflammatory cellular environment is increased as well
(Park & Kang, 2013). However, the causes of increased disease risk, and associated proinflammatory environment, among AA women have not been fully explained. Some
studies have shown that AAs have a higher level of IL-6 (a pro-inflammatory cytokine)
compared to CAs (Kalra et al., 2005; Walston et al., 2007). Another potential explanation
may be due partially to socioeconomic status; a low socioeconomic status has been
correlated with an increase of C-reactive protein, IL-6, and TNF- (Paalani, Lee,
Haddad, & Tonstad, 2011).
Over-nutrition promotes a dysregulation of energy storage and utilization, causing
an activation of local inflammatory pathways and compromised metabolic function
(Calcada et al., 2014; Hotamisligil & Erbay, 2008). This compromise in metabolic
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function can lead to the inability to switch between different macronutrition oxidation,
this inability is known as metabolic inflexibility and can lead to inflammatory disease
states (Muio, 2014). Berk et al. (2006) found that obese AA women were not able to
efficiently switch between fat oxidation (fasting state) and carbohydrate oxidation (fed
state); suggesting that this AA population may have decreased metabolic flexibility.
Given the responsiveness of the immune system to dietary stimuli, one potential
explanation may be that certain immune cells may be more pro-inflammatory in response
to certain types of dietary stimuli, among AA women compared to CA women. If
immune cells, such as PBMCs, from AA women display a more pro-inflammatory profile
in response to dietary stimuli, such as lipid incubation or consumption of a high fat meal,
this may contribute to increased disease risk.
While it is seen that immunity can affect overall disease state, weight status is
gaining acceptance as a predictor of severe health complications. Between 2011 and 2014
it is estimated that 36.5% of Americans were categorized as obese (Ogden et al., 2015).
Obesity has been associated with several health effects, such as mortality, hypertension,
type-2 diabetes, coronary heart disease, low quality of life (Bhaskarn et al., 2014;
NHLBI, 1998; NHLBI, 2014); as well as mental illness (Kasen et al., 2008; Luppino et
al., 2010) and difficulty with physical functioning (Roberts et al., 2003). Epidemiological
studies have shown a foundational association between obesity, type-2 diabetes, and
cancer (LeRoith et al., 2008). With greater prevalence of obesity-driven type 2 diabetes
(Ogden et al., 2006), the prediction of increased cancer rates and subsequently an
increase of cancer deaths can be plausible (LeRoith et al., 2008).
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Along with the systemic complications that an elevated weight status can cause,
there is also a state of low-grade inflammation due to an increase in pro-inflammatory
cells (Lumeng & Saltiel, 2011). Low-grade inflammation is often measured by increased
levels of C-reactive protein and other pro-inflammatory cytokines (Hotamisligil, 2006). A
greater presence of pro-inflammatory cells increases the probability of disruptions in
metabolic health (Phillips & Perry, 2013), such as the pathogenesis of insulin resistance.
Additionally, the chronic low-grade inflammatory state is associated with an increased
prevalence of cardiovascular disease and many other maladies (Rodriguez-Hernandez,
Simental-Mendia, Rodriguez-Ramierz, & Reyes-Romero, 2013).
Altered levels of metabolic genes and RNA transcripts have been associated with
obesity, insulin resistance, and weight gain (Gao & Liu, 2014); due to obesity being
associated with an increased risk of hyperlipidemia, hyperglycemia, hypertension,
atherosclerosis, and chronic heart disease (Adams et al., 2006; Gade, Schmit, Collins, &
Gade, 2010; Hedley et al., 2004; Hossain, Kawar, & El Nahas, 2007; Kolovou,
Anagostopoulu, & Cokkinos, 2005). Obesity has serious metabolic consequences such as
developing resistance to insulin and leptin, dyslipidemia related to increased visceral
adipose tissue, chronic inflammation leading to atherosclerosis, and lipotoxic damage to
tissues and vasculature; all of which result in a dramatic increase in cardiovascular
disease (Gade et al., 2010).
Gene expression alterations among PBMCs may represent overall systemic health
(Afman, Milenkovic, & Roche, 2014). Because of the representation of systemic health
and the effects of long-term dietary interventions on lipid metabolism (Bouwens et al.,
2009; De Mello et al., 2009; Myhrstad et al., 2014; van Dijk, Feskens, et al., 2012),
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PBMCs can serve as a model for examining early risk markers to dietary changes (Leder
et al., 2016; Visvikis-Siest et al., 2007). Changes in lipid homeostasis due to an acute
challenge are linked to inflammatory status (Leder et al., 2016). Thus, PBMC gene
expression changes may represent metabolic health changes (O’Grada et al., 2014).
Obesity is related to immune and inflammatory system responses contributing to
an abnormal regulation of pro-inflammatory cytokines (Bastard et al., 2000; Juge-Aubry
et al., 2004; Meier et al., 2002; Moon, Kim, & Song, 2004; Park, Park, & Yu, 2004).
Alterations in gene expression of PBMCs, in obese individuals, have been found to affect
lymphocyte function due to the abnormal metabolism of cytokines (O’Rourke et al.,
2006). Metabolic diseases, such as obesity, metabolic syndrome, and type-2 diabetes, are
associated with modified immune response and lipid metabolism; food challenges that
alter these responses may play an important role in the detection and prevention of these
diseases (van Ommen et al., 2009). Regarding metabolic regulatory genes, PBMCs could
serve as a potential source for inflammatory biomarkers in early homeostatic imbalance
(Oliver, Reynes, Caimari, & Palou, 2013). While most studies, similar to Bruun et al.
2006, investigating weight and inflammatory status involve a prolonged dietary and/or
exercise intervention, there is limited research examining the effects of an acute change
on inflammatory status of PBMCs.
Along with weight status contributing to altered systemic inflammation, ethnic
differences have been found to effect gene expression in inflammatory disease. It has
been found that gene expression of PBMCs differs between AA and CA women,
suggesting molecular factors attributing to inflammatory disease, such as hypertension
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and atherosclerosis (Dluzen et al., 2016). Currently, there is limited research investigating
cytokine gene expression of PBMCs, particularly in response to an acute dietary stimulus.
To the principal investigator’s knowledge, there is no current data on the PBMCs
response (in vivo) to an acute high fat meal among lean and obese AA and CA women. In
addition, no study has investigated the (in vitro) lipid stimulated response of cultured
PBMCs from lean and obese AA and CA women. Therefore, the purpose of this study
was to examine PBMC response to lipid oversupply in vivo (in response to consuming a
high fat meal) and in vitro (in response to culturing PBMCs in media supplemented with
lipid) among AA and CA women. The secondary purpose was to determine the impact
that weight status may have on this response.
These experiments will provide insight into how the immune system is linked to
lipid metabolism, inflammation, and dietary intake. More specifically, these results may
uncover ethnic and/or weight status differences in how certain immune cells respond to a
dietary intake and/or lipid stimulus. If ethnic differences are discovered, this may help
explain why AA women have disproportionately higher rates of obesity, metabolic
disease, and other chronic inflammatory-related diseases. Additionally, if weight status
differences are found this may aid in the current knowledge of how chronic low-grade
inflammation and the immune system are associated with weight statuses of women.
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Chapter 2. Literature Review
Obesity
Weight status is gaining acceptance as a predictor of severe health complications.
Between 2011 and 2014 it is estimated that 36.5% of Americans were categorized as
obese (Ogden et al., 2015). As a means of measuring an individual’s weight status, body
mass index (BMI) is now considered a standard measure of obesity. BMI is found by
dividing weight in kilograms by height in meters squared (BMI=kg/m2) (Pescatello &
American College of Sports Medicine (ACSM), 2014), and although this method of
categorizing weight status is an easy tool, it does not properly display the location of
adipose tissue, which may be a determinant in risk stratification (Eckel, 1997).
Obesity has been associated with several health effects, such as mortality,
hypertension, type-2 diabetes, coronary heart disease, low quality of life (Bhaskarn et al.,
2014; NHLBI, 1998; NHLBI, 2014); as well as mental illness (Kasen et al., 2008;
Luppino et al., 2010) and difficulty with physical functioning (Roberts et al., 2003). The
association between obesity and coronary heart disease is well established (Manson et al.,
1990; Prospective Studies Collaboration et al., 2009) primarily due to the exacerbated
rate of atherosclerosis (Shimano, 2009). Epidemiological studies have shown a
foundational association between obesity, type-2 diabetes, and cancer (LeRoith et al.,
2008). With greater prevalence of obesity-driven type-2 diabetes (Ogden et al., 2006), the
prediction of increased cancer rates and subsequently an increase of cancer deaths can be
plausible (LeRoith et al., 2008).
Along with the large systems complications that an elevated weight status can
cause, there is also a state of low-grade inflammation due to an increase in pro-
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inflammatory cells (Lumeng & Saltiel, 2011). Low-grade inflammation is often measured
by increased levels of C-reactive protein and other pro-inflammatory cytokines
(Hotamisligil, 2006). This increased amount of pro-inflammatory cells increases the
probability of disruptions in metabolic health (Phillips & Perry, 2013) such as the
pathogenesis of insulin resistance. Additionally, the chronic low-grade inflammatory
state is associated with an increased prevalence of cardiovascular disease, diabetes,
metabolic syndrome, and many other maladies (Rodriguez-Hernandez, Simental-Mendia,
Rodriguez-Ramierz, & Reyes-Romero, 2013). Consequently, the reduction of proinflammatory biomarkers is associated with increased likelihood of a metabolically
healthy individual (Phillips & Perry, 2013).
The elevated prevalence of obesity, coupled with other socio-economic burdens
associated with obesity, emphasizes the critical need for understanding the molecular
mechanisms associated with the obese state. Altered levels of metabolic genes and RNA
transcripts are associated with obesity, insulin resistance, and weight gain (Gao & Liu,
2014). Due to obesity being associated with an increased risk of hyperlipidemia,
hyperglycemia, hypertension, atherosclerosis, and chronic heart disease (Adams et al.,
2006; Gade, Schmit, Collins, & Gade, 2010; Hedley et al., 2004; Hossain, Kawar, & El
Nahas, 2007; Kolovou, Anagostopoulu, & Cokkinos, 2005). Obesity has serious
metabolic consequences such as developing resistance to insulin and leptin, dyslipidemia
related to increased visceral adipose tissue, chronic inflammation leading to
atherosclerosis, and lipotoxic damage to tissues and vasculature; all of which result in a
dramatic increase in cardiovascular disease (Gade et al., 2010).
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Gender
The United States showed a greater prevalence of obesity prevalence in 19992002 compared to other developed countries, with the variance largely due to the higher
prevalence seen among women (Flegal, Carroll, Ogden, & Curtin, 2010; Tjepkema,
2006). Between 2011 and 2014, women have shown an increased prevalence of obesity,
38.3%, compared to men, 34.3% (Ogden et al., 2015). With this increasing trend of
obesity among women, research examining possible physiological changes aiding in the
increasing obesity prevalence among women is warranted.
African American Health
African Americans and Overall Health Differences
The predominance of cardiovascular risk, obesity, high cholesterol, and
hypertension is increased among AA women compared to CAs (Malayala & Raza, 2016).
African Americans also have increased insulin resistance when compared to CAs (Meis,
Schuster, Gaillard, & Osei, 2006), which is a direct indication that the action of insulin at
the tissue level is impaired (Kasim-Karakas, 2000). Additionally, AAs have a
disproportionately higher coronary heart disease mortality and morbidity (Clark et al.,
2001).
AA and Inflammation
With an increase in disease risk among AA women (Taylor et al., 2008) the
likelihood of an increased pro-inflammatory cellular environment is increased as well
(Park & Kang, 2013). However, the causes of increased disease risk and associated proinflammatory environment among AA women have not been fully explained. Some
studies have shown that AAs have a higher level of IL-6 (as a pro-inflammatory
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cytokine) compared to CAs (Kalra et al., 2005; Walston et al., 2007). Another potential
explanation may be due partially to socioeconomic status; a low socioeconomic status has
been link with an increase of C-reactive protein, IL-6, and TNF- (Paalani, Lee, Haddad,
& Tonstad, 2011).
AA, Diet, and Immunity
Over-nutrition promotes a dysregulation of energy storage and utilization, causing
an activation of local inflammatory pathways and compromised metabolic function
(Calcada et al., 2014; Hotamisligil & Erbay, 2008). This compromise in metabolic
function can lead to the inability to switch between different macronutrition oxidation,
this inability is known as metabolic inflexibility and can lead to inflammatory disease
states (Muio, 2014). Berk et al. (2006) found that obese AA women were not able to
efficiently switch between fat oxidation (fasting state) and carbohydrate oxidation (fed
state); demonstrating that the AA population has decreased metabolic flexibility. Given
the responsiveness of the immune system to dietary stimuli, it is plausible that certain
immune cells may be more pro-inflammatory in response to certain types of dietary
stimuli, particularly in AA women when compared to CA women. If immune cells, such
as PBMCs, from AA women display a more pro-inflammatory profile in response to
dietary stimuli, such as lipid incubation or consumption of a high fat meal, this may
contribute to increased disease risk.
Metabolism and Immunity
The immune system plays a vital role in the prevention and development of many
diseases, including cardiovascular and metabolic disease (Drew, 2012). The control of
the immune system and other cellular defense systems, e.g. metabolism, are interlinked
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and require a network of communication between immune cells to direct defense and
respond to the environment (Drew, 2012). These systems are highly responsive to an
acute high fat dietary intake, which can modulate a variety of physiological processes
(Drew, 2012), such as the upregulation of pro-inflammatory cell signaling (Monterio &
Azevedo, 2010).
While there is a split seen when discussing the metabolic states of innate or
adaptive immune cells, both groups transition from naive to activated states in response
to stimuli (Ganeshan & Chawla, 2014). The innate immune system consists of
neutrophils, mast cells, macrophages, and dendritic cells. Neutrophils make up
approximately 50-60% of circulating leukocytes and perform host defense functions,
such as the phagocytosis of invading pathogens (bacteria and/or fungi) (Segal, 2005).
This phagocytosis phases result in changes to the metabolic state of neutrophils
(Ganeshan & Chawla, 2014). Mast cells are responsible for functions that involve wound
healing and defense against pathogens, venoms, and toxins (Abraham & St John, 2010);
these functions require mast cells to rapidly degranulate (Ganeshan & Chawla, 2014).
While the energy demands of mast cell degranulation and regranulation are likely to be
high, little is known about how the metabolic demand is met (Ganeshan & Chawla,
2014). Macrophages serve as a first line of defense against foreign bodies and participate
in tissue homeostasis (Wynn, Chawla, & Pollard, 2013). Macrophages can undergo
distinct activation programs resulting is two characterized states, classical (M1) and
alternative (M2) (Ganeshan & Chawla, 2014). Classically activated macrophages aid in
the protection against pathogens by escalating a pro-inflammatory response by releasing
cytokines like IL-6 and TNF- (Ganeshan & Chawla, 2014). Alternatively activated
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macrophages act as a hot defense system against infections by regulating the innate and
adaptive immune system responses in addition to facilitating the formation of granulation
(Ganeshan & Chawla, 2014). The glycolytic and oxidative metabolism is crucial in the
promotion of the maturation of classically and alternatively activated macrophages
(Ganeshan & Chawla, 2014). However, in dendritic cells, glycolysis may be necessary to
provide intermediates required for the early stages of cellular activation (Ganeshan &
Chawla, 2014). Studies show that the metabolic reprogramming of dendritic cells by tolllike receptor ligands may be responsible for functions that drive the maturation of an
immune response (Ganeshan & Chawla, 2014).
The main roles of adaptive immune cells are cytokine and chemokine production.
These cells also have functions that must be supported by cataplerotic and anaplerotic
reactions of cell level metabolism (Ganeshan & Chawla, 2014). Most research that
focuses on adaptive immune system is geared towards CD4+ T cells, but similarities can
be associated with CD8+ T cells and B cells. Naïve CD4+ T cells are metabolically
active and require ATP synthesis for migration where they actively sample antigens
(Ganeshan & Chawla, 2014). The formation of CD8+ T cells, or memory T cells, are
dependent on fatty acid oxidation and mitochondrial oxidative metabolism (Pearce et al.,
2009; Van der Windt et al., 2012). B cells are the sole producers of antibodies that
establish and maintain humoral immunity (Ganeshan & Chawla, 2014). Though, the
unique features of B cells, like antibody class switching, affinity maturation, and plasma
cell formation, have not yet been thoroughly investigated (Ganeshan & Chawla, 2014).
An essential step in the maturation of immune cells is the reprograming of their
metabolic profiles, which is a result of a response to extracellular stimuli (Ganeshan &
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Chawla, 2014). Metabolic control of circulating immune cells can be a representation of a
systemic response of the whole body. Despite this knowledge, the understanding of
immune cell metabolism is still not fully clear and warrants further investigation.
Peripheral Blood Mononuclear Cells
Peripheral blood mononuclear cells collectively refer to a heterogeneous mixture
of mononuclear immune cells (Koncarevic et al., 2014), and are defined as any blood cell
having a round nucleus; this includes T cells, B cells, natural killer cells and monocytes
and are an imperative component of the immune system (Arosio et al., 2014). In recent
years, the investigation of how PBMCs, as a representor of systemic immune response,
are related to metabolic biomarkers and disease has ensued (Bouwens et al., 2010;
Stepien et al., 2014). Recent studies have provided information about unique gene
expression from PBMCs from patients with lupus, multiple sclerosis, cancer, and
rheumatoid arthritis (Aune, Maas, Parker, Moore, & Olsen, 2004; Edwards et al., 2007;
Mandal, Gurevich, Pauzner, Kaminski, & Achiron, 2004; van ‘t Veer et al., 2002); all of
which are systemic inflammatory diseases. The investigation of PBMCs could serve as a
model to investigate the link between immune function, inflammation, and metabolic
disease.
Cytokines
It is important to assess the inflammatory state of circulating immune cells
because of the alterations in gene expression, found specifically in PBMCs, affecting
other cellular function (Aune et al., 2004; Edwards et al., 2007; Mandal et al., 2004;
O’Rourke et al., 2006; van ‘t Veer et al., 2002). Cytokines are a broad category of small
proteins that play an important role in immune function, metabolism, life-style related-
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disease, and overall health (Duque & Descoteaux, 2014; Friberg, Bryant, Shannon, &
Whiteside, 1994; Katial, Sachanandanim, Pinney, & Lieberman, 1998). These proteins
can be produced and released by peripheral blood mononuclear cells (Friberg et al.,
1994). In an obese population, it is believed that the higher concentration of proinflammatory cytokines play a role in insulin resistance (Rodriguez-Hernandez et al.,
2013).
Interleukin 6 (IL-6) is a cytokine that is synthesized by adipose tissue, endothelial
cells, macrophages, and lymphocytes. This cytokine plays a vital role in multiple systems
and processes, to include bone metabolism, inflammation, and acute phase reactions;
while regulating energy homeostasis and inflammation (Rodriguez-Hernandez et al.,
2013). Interleukin 6 can act as a pro- or anti-inflammatory cytokine; where as a proinflammatory cytokine is mediated by trans-signaling (Scheller, Chalaris, Schmidt-Arras,
& Rose-John, 2011). Cells which only expression the signaling receptor protein gp130
are not response to IL-6 alone, but can response to a complex that is naturally bound to
the soluble form of the IL-6 receptor, this adaptability can greatly enlarge the spectrum of
IL-6 target cells that can be activated through trans-signaling (Scheller et al., 2011).
Conversely, IL-6 can act as an anti-inflammatory, or regenerative, cytokine which is
mediated by classic signaling (Scheller et al., 2011). This can occur once IL-6 stimulates
the target cells via a membrane bound receptor, then signal transducers and activators of
transcription factors are recruited which are dimerized, where they translocate into the
nucleus and activate the target genes (Scheller et al., 2011). This cytokine is important in
the transition from acute inflammation to chronic inflammation, which plays a pivotal
role in the promotion of disease such as obesity, insulin resistance, and inflammatory
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arthritis (Naugler & Karin, 2008; Rodriguez-Hernandez et al., 2013), by changing the
nature of leucocyte infiltration from polymorphonuclear neutrophils to macrophages
(Gabay, 2006). Additionally, IL-6 increase hepatic lipogenesis (Feingold & Grunfeld,
1992) and can trigger an acute-phase response (Baumann & Gauldie, 1994).
Interleukin 8 (IL-8) is one of the most widely studied pro-inflammatory cytokines
(Turner, Nedjai, Hurst, & Pennington, 2014), which is responsible for the targeted
recruitment of neutrophils (Bickel, 1993; Hammond et al., 1995). While having roles in
chemotactic migration and activation of monocytes, lymphocytes, basophils, and
eosinophils at sites of inflammation (Miller et al., 1992), IL-8 is strongly stimulated by
IL-1 and TNF- (Qazi, Tang, & Qazi, 2011). Interleukin 8 can also recruit T cells and
other nonspecific inflammatory cells to the sites of inflammation (Schroder, 1992). IL-8
plays a pivotal role by attracting mononuclear cells to the sites of infection or
inflammation (Shin, Szuba, & Rockson, 2002), leading to the initiation and progression
of inflammatory statuses such as atherosclerosis (Niculescu & Rus, 1999) which it has
been suggested to have a common inflammatory basis as other metabolic disease
(Pradhan & Ridker, 2002). Additionally, an increase of glucose concentrations has been
seen to induce the expression of IL-8, which eludes to the development of
hyperglycemia, inflammatory statuses, and atherosclerosis (Temaru et al., 1997).
Interleukin 10 (IL-10) is an anti-inflammatory cytokine produced by leukocytes,
dendritic cells, macrophages, mast cells, natural killer cells, eosinophils, neutrophils,
CD4 and CD8 T cells and B cells and represses extreme inflammatory responses
(Ouyang, Rutz, Crellin, Valdez, & Hymowitz, 2011). Interleukin 10 derived from
macrophages inhibit the differentiation of neighboring cells into classically activated
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macrophages; this allows these macrophages to be self-regulated (Sing et al., 2002).
Additionally, IL-10 inhibits innate and adaptive immune system responses which limit
possible tissue damage caused by inflammation (Ouyang et al., 2011).
Tumor necrosis factor alpha (TNF-) is a pleiotropic molecule that promotes the
secretion of other pro-inflammatory cytokines and reduces anti-inflammatory responses,
due to this it plays an essential function in inflammation, the immune system, and
metabolism (Rodriguez-Hernandez et al., 2013). This being said, TNF- is increased in
an obese population and promotes insulin resistance by inhibiting insulin receptor
substrate signaling pathways (Hotamisligil et al., 1996; Rodriguez-Hernandez et al.,
2013; Wang & Trayhurn, 2006).
Population Differences in Cytokine and PBMC Expression
Gene expression alterations among PBMCs may represent overall systemic health
(Afman, Milenkovic, & Roche, 2014). Because of the representation of systemic health
and the effects of long-term dietary interventions on lipid metabolism (Bouwens et al.,
2009; De Mello et al., 2009; Myhrstad et al., 2014; van Dijk, Feskens, et al., 2012).
PBMCs can serve as a model for examining early risk markers to dietary changes (Leder
et al., 2016; Visvikis-Siest et al., 2007). Changes in lipid homeostasis due to an acute
challenge are linked to inflammatory status (Leder et al., 2016). Thus, PBMC gene
expression changes may represent metabolic health changes (O’Grada et al., 2014).
Obesity has been connected with immune and inflammatory system responses
contributing to an abnormal regulation of pro-inflammatory cytokines (Bastard et al.,
2000; Juge-Aubry et al., 2004; Meier et al., 2002; Moon, Kim, & Song, 2004; Park, Park,
& Yu, 2004). Alterations in gene expression of PBMCs, in obese individuals, have been
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found to affect lymphocyte function due to the abnormal metabolism of cytokines
(O’Rourke et al., 2006). Metabolic diseases, such as obesity, metabolic syndrome, and
type-2 diabetes are associated with immune response and lipid metabolism; food
challenges that alter these responses may play an important role in the detection and
prevention of these diseases (van Ommen et al., 2009). Regarding metabolic regulatory
genes, PBMCs could serve as a potential source for inflammatory biomarkers in early
homeostatic imbalance (Oliver, Reynes, Caimari, & Palou, 2013). While most studies,
similar to Bruun et al. 2006, investigating weight and inflammatory status involve a
prolonged dietary and/or exercise intervention, there is limited research examining the
effects of an acute change on inflammatory status of PBMCs.
Along with weight status contributing to systemic inflammatory changes, ethnic
differences have been found to effect gene expression in inflammatory disease. Research
suggests that gene expression of PBMCs differs between AA and CA women, suggesting
molecular factors attributing to inflammatory disease, such as hypertension and
atherosclerosis (Dluzen et al., 2016). Currently, there is limited research investigating
cytokine gene expression of PBMCs, particularly in response to an acute dietary stimulus.
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Chapter 3. Methods
Informed Consent and IRB Approval
This study received Western Kentucky University (WKU) Institute Review Board
(IRB) approval (IRB # 17-021) on August 28th, 2016. All subjects were recruited from
WKU and the Bowling Green, KY community via paper flyers and targeted emails.
Before participations, subjects signed an IRB approved Informed Consent (Appendix A),
in a private location, to maintain confidentiality. A principal investigator or coinvestigator verbally guided each subject through the informed consent, while allowing
time for the subject to ask any questions. Each subject received a copy of the informed
consent in which they signed.
Subject Recruitment
All subjects that participated in the study were recruited from WKU and the
greater Bowling Green, KY area. Initially AA subjects were recruited, then CA subjects
were matched via age, weight, BMI, and health status. This method of subject
recruitment resulted in 21 subjects, with 10 AA and 11 CA women participating in the
study. All subjects were women between the ages of 20-37 years old, non-smokers, and
not currently using any drugs to alter insulin resistance and/or metabolic profiles.
Subject Involvement
Initial Shake Ingestion
All data collection for initial shake ingestion occurred at the Exercise Research
Laboratory, housed within the Department of Physical Therapy, at the WKU Medical
Center Health Complex. All recruited subjects were asked to consume a standardized
meal the evening prior to their appointment (Appendix B). This meal consisted of a
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standardized diet consisting of approximately 50% carbohydrate, 30% fat, and 20%
protein. Subjects were asked to select a meal category based on initial BMI assessment of
lean, overweight, or obese. Subjects prepared this meal on their own/at-home and to fast
after consuming the meal.
Subjects reported to the Exercise Research Laboratory after an approximate 10hour fast. The subject’s weight, height, and vital signs were taken upon arrival to the
laboratory. Body composition was measured using skinfold anthropometry, using a
seven-site protocol to determine percent body fat (Pescatello & ACSM, 2014). A
Harpenden Skinfold Caliper was used to measure skinfolds, which at a later point was
entered into a standardized equation to estimate body fat percentage of each subject.
A baseline blood draw (~20 mL) was obtained via butterfly angiocatheter in the
antecubital region of the arm or the posterior surface of the hand. The angiocatheter was
flushed with saline to maintain patency at each time point blood draw. After the baseline
blood draw, subjects consumed a standard ~ 1000-kcal high fat shake, similar in
composition to previous studies (Heilbroon, Gregersen, Shirkhedkar, Hu, & Campbell,
2007; Jakulj et al., 2007). The high-fat shake consisted of 1062 calories, 55.93% fat,
which was obtained from a local smoothie shop. The smoothie contained almond milk,
banana, apple, peanut butter, super grains, cocoa, vegan protein, and almond. This
smoothie was similar in fat content to an average high fat meal found in the standard
western diet, but compiled from healthier food sources to reduce the risk of
gastrointestinal discomfort. An additional blood draw (~20 mL) was taken from the same
angiocatheter, four hours after the high fat shake was ingested. At the end of the study,
the angiocatheter was removed by the attending nurse practitioner. During the four hours
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post shake ingestion, the subject was asked to sit or recline comfortably, while being
allowed to talk on the phone, work on a portable device, or watch TV.
Additionally, during the four-hour study period, subjects were asked to complete
several surveys, including the National Institutes of Health’s validated Dietary History
Questionnaire II to determine potential differences in normal diet and the International
Physical Activity Questionnaire to determine domain and mode of physical activities.
All study procedures were supervised by a doctor of nursing practice or a
physician trained in Syria with 5 years experienced working in diagnostics. Dr.
Blankenship and Nuha Shaker provided clinical expertise in supervising the subject to
ensure patient safety. Dr. Blankenship and Nuha Shaker were responsible for venous
blood draws conducted in this study.
Before the conclusion of the subject’s appointment and after the angiocatheter
was removed, subjects were given an ActiGraph Link Accelerometer (ALA) (ActiGraph
LLC, Pensacola, FL) to objectively confirm their self-reported physical activity levels.
The ALA was placed on the non-dominant wrist with non-removable hospital-grade
wristbands. This specific tri-axel accelerometer was chosen because it can be used as a
valid measure of physical activity energy expenditure in women (Plasqui & Westerterp,
2007). Data was collected for seven consecutive days at 30 Hz. The accelerometer output
was sampled by a 12-bit analog-to-digital converter. The percentage of time spent in
sedentary activity, as well as the amount of time spent participating in different categories
of physical activity ranging from light and lifestyle to moderate, was calculated using
algorithms corresponding to the following activity counts: sedentary: 0 - 99 counts/min,
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light: 100 - 759 counts/min, lifestyle: 760 - 1951 counts/min, moderate: 1952-5724
counts/min (Freedson, Melanson & Sirard, 1998).
Sample Transportation and Subsequent Procedures
Transportation of Biological Samples
All biological samples were transported to the WKU Exercise Biochemistry
Laboratory (Biosafety Level 2) at approximately +20°C to preserve the integrity of the
sample. Once samples arrived at the WKU Exercise Biochemistry Laboratory, they were
immediately processed; time between blood draw and initiation of isolation was less than
2 hours.
PBMC Isolation
All blood samples were captured in a 10 mL EDTA vacutainer and immediately
transported to begin processing for isolation and culturing of PBMCs using a ficoll
gradient protocol (Histopaque-1077, Sigma-Aldrich, St. Louis, MO). The specific
protocol used is as follows:


Add two 5 mL aliquots to 5 mL phosphate buffered saline (PBS) and gently
homogenized.



Layer whole blood: PBS mixture (~10 mL) onto 3 mL Histopaque-1077.



Spin @ 400 xg for 20 min @ room temperature (RT).



Transfer PBMC layer to a new 15 mL conical tube.



Add 9 mL PBS and gently homogenized.



Spin @ 100 xg for 10 min @ RT, discarded the supernatant and resuspended
pellet.



Add 9 mL PBS and gently homogenized.
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Spin @ 100 xg for 10 min @ RT, discarded the supernatant and resuspended
pellet.

PBMC Culture and Storage of Supernatant
PBMCs were cultured in two different dishes for three hours in one of two
different conditions: 1) in RPMI-1640 media supplemented with 10% FBS (control
condition) and 2) in RPMI-1640 media supplemented with 10% FBS and 250 micromolar
1:1 Oleate Palmitate lipid mixture (lipid-treated condition) (Maples et al., 2015). The
specific protocol used is as follows and continues with PBMC Isolation Protocol:


For one sample, add 2 mL of lipid incubation media and transfer to a 35-mm
cell culture dish.



For one sample, add 2 mL of RPMI-1640 control media and transferred to a
35-mm cell culture dish.



Incubate @ +37°C for 3 hours.



Remove supernatant and transfer to a 2 mL microcentrifuge tube, then store @
-80°C.



Add 400 μL PBS, scrap cells, and transfer cell suspension to a 2 mL
microcentrifuge tube for RNA isolation.

RNA Isolation and Storage
PBMC RNA isolation was performed according to manufacturer’s protocol using
the TRIzol Reagent method to isolate RNA (Thermo Fisher Scientific Inc., Waltham,
MA). RNA isolation immediately followed PBMC isolation and culture. The specific
protocol used is as follows and continues with PBMC Culture and Storage of
Supernatant:
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Add 400 μL PBMC sample to 1,200 μL TRIzol, lysis by pipetting and
incubate @ RT for 5 min.



Add 240 μL chloroform and vortex for 15 secs, incubate for 3 min @ RT.



Spin @ 12,000 xg for 15 min @ +4°C.



Remove and transfer the colorless upper aqueous phase to a new 2 mL
microcentrifuge tube.



Add 600 μL 99.5% isopropanol.



Incubate @ -20° C for overnight.



Spin @ 12,000 xg for 10 min @ +4°C.



Remove supernatant and add 1,200 μL 75% ETOH.



Spin @ 7,500 xg for 5 min @ +4°C.



Remove supernatant and let air dry for 15 min @ RT.



Resuspend in 20 μL of RNase-free water.



Incubate @ +60°C for 15 min.



Store @ -80°C, allowing to let warm to RT before quantifying, making sure to
keep on ice.

RNA Quantitation
RNA was tested for quantity and purity using ultraviolet absorbance at 230nm,
260nm, and 280nm Spectrophotometry was performed in triplicate using a Synergy HTX
Multi-Mode Reader (BioTek Instruments, Inc., Winooski, VT).
cDNA Reverse Transcription
Reverse transcription of RNA to cDNA was conducted using an Applied
Biosystems High-Capacity cDNA Reverse Transcription Kit. Reverse transcription of
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performed by manufacture’s protocol to yield 1 μg per 20 μL using a Mastercycler
thermocycler (Eppendorf, Hauppauge, NY) which is as follows:


Prepare 2x RT master mix (without RNase Inhibitor) by combining:
o 2.00 μL 10x RT Buffer
o 0.80 μL 25x dNTP Mix (100 mM)
o 2.00 μL RT Random Primers
o 1.00 μL MultiScrib Reverse Transcriptase



Add 2x RT master mix with appropriate volume of RNA to yield 1ug.



Add remaining amount of Nuclease-free H2O to yield a total volume of 20 μL.



Briefly centrifuge the spin down contents.



Program thermal cycler conditions listed below:
o Step 1: 25C for 10 min
o Step 2: 37C for 120 min
o Step 3: 85C for 5 min
o Step 4: Hold at 4C



Set reaction volume to 20 μL.



Start the reverse transcription run.



After the reverse transcription run is complete, store samples at -20C.

Reverse Transcription Polymerase Chain Reaction (RT-PCR)
PCR was performed in triplicate using the Applied Biosystems ABI 7300
sequence detection instrument and software with TaqMan Universal PCR Master Mix
and TaqMan gene expression assays (Applied Biosystems, Foster City, California) in
accordance with manufacturer’s instructions. Using standard techniques, reactions were
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run with the following thermal cycling conditions: 50˚C for 2 min; 95˚C for 10 min; and
40 cycles of 95˚C for 15 s; followed by 60˚C for 1 min. mRNA content was measured
using the relative Ct method, compared to as endogenous control (B2M) and converted to
a linear function by using a base 2 antilog transformation.
Statistical Analysis
Statistical analyses were performed using SPSS Statistics 23 Software (SPSS,
Chicago, IL) on log-transformed data. Using RT-PCR, we evaluated gene expression of
IL-6, IL-8, IL-10, and TNF-. To determine the impact that ethnicity may have on
PBMC gene expression in response to the high fat shake consumption and lipid-treatment
of cultured PMBCs, a repeated-measures ANOVA with emphasis on a time (pre- vs.
post-shake) X treatment (control, lipid-treated) X ethnicity (AA vs. CA) interaction were
performed. To determine the impact of weight status on PBMC response, a repeatedmeasures ANOVA with emphasis on a time (pre- vs. post-shake) X treatment (control,
lipid-treated) X weight status (lean <27 BMI vs Obese >27 BMI) interaction were
performed. All data met assumptions of sphericity and homogeneity of variance. Data are
presented as means +/- SD.
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Chapter 4. Results
Subject Characteristics
Subject characteristics are presented in Table 1. Table 1 describes an ethnicity
subset to include 21 women, 10 AA (age: 28.00±6.60) and 11 CA (age: 26.91±6.28),
which were used when analyzing ethnical difference between women, and weight status
subset to include 21 women, 11 lean (age: 26.275.10; BMI<27.0) and 9 obese (age:
28.677.92, BMI≥27.0), which were used to examine weight status differences between
women. There were no significant differences seen between lean and obese AA and CA
in age, SBP, DBP, resting glucose; while BMI between lean and obese AA and CA were
significantly different.
Table 1. Subject Characteristics

All
Age
BMI
SBP
DBP
Glucose
AA
Age
BMI
SBP
DBP
Glucose
CA
Age
BMI
SBP
DBP
Glucose

All
N=21
27.436.30
30.7710.30
120.6713.41
76.0011.70
96.2413.48
N=10
28.00±6.60
29.836.57
122.78±17.13
75.50±16.00
94.5012.95
N=11
26.91±6.28
31.6313.10
118.9010.18
76.407.69
97.8114.37

Lean
N=11
26.275.10
23.831.32
120.5010.93
76.206.99
95.3667.30
N=5
27.004.90
24.241.46
117.0014.94
74.2511.35
97.006.93
N=7
26.145.30
23.761.33
119.2911.91
74.717.67
94.007.26
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Obese
N=9
28.677.92
39.8510.04
124.1415.19
78.2915.96
97.567.92
N=5
29.008.46
35.414.14
128.7519.22
76.7521.55
92.0017.71
N=4
28.258.46
45.3913.12
118.006.25
80.337.51
104.5022.13

P-Value
0.48
0.001
0.40
0.53
0.71
P-Value
0.66
0.002
0.37
0.84
0.57
P-Value
0.62
0.05
0.87
0.32
0.27

Gene Expression
Time and Treatment
First, the response of PBMCs to lipid oversupply was assessed among all
participants in the study. Overall, there was no significant change in IL-6 expression for
all participants in the control condition pre- vs. post-shake consumption (Figure 1 Panel
A); however, there was an overall trend for a decrease in the expression of IL-6 postshake (compared to pre-shake) in the lipid-treated condition (pre- 3.11±0.61 vs. post2.77±0.59; p=0.06) (Figure 1 Panel B). There was a significant time effect for IL-8 gene
expression (p=0.04), where IL-8 expression significantly increased post-shake in both the
control (pre- 5.28±0.36 vs post-5.46±0.27; p=0.05) and lipid-treated (pre- 5.33±0.31 vs.
post- 5.60±0.35; p=0.01) conditions for all subjects (Figure 2). There was no significant
treatment effect (control vs. lipid) for TNF- (pre- p=0.95; post- p=0.45), IL-6 (prep=0.25; post- p=0.49), IL-8 (pre- p=0.88; post- p=0.12), or IL-10 (pre- p=0.99; postp=0.59).
Ethnic Differences
To assess the impact that ethnicity has on PBMC response to lipid oversupply, all
AA women were collapsed into one group (AA) and all CA women were collapsed into
one group (CA). There were no baseline differences between ethnic groups in TNF-, IL6, IL-8, and IL-10 expression (pre-shake, control and lipid-treated) (Table 2). For IL-6
gene expression, the interaction between time X treatment X ethnicity approached
significance (p=0.07) and a significant time X treatment interaction (p=0.04) was
observed. Among the AA women only there was a significant decrease in IL-6 gene
expression post-shake (compared to pre-shake) in the lipid-treated condition (pre-
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3.22±0.64 vs. post- 2.54±0.59; p=0.04) (Figure 1 Panel B). In the post-shake, control
condition IL-8 gene expression was significantly higher among the AA women (AA
5.84±0.38 vs. CA 5.48±0.30; p=0.03) (Figure 2 Panel A).

Table 2. Baseline Differences in AA and CA Gene Expression

IL-6
IL-8
IL-10
TNF-

Lipid
Control
Lipid
Control
Lipid
Control
Lipid
Control

AA
3.23±0.60
3.14±0.43
5.34±0.31
5.49±0.22
3.26±0.19
3.20±0.38
4.64±0.20
4.67±0.08
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CA
3.13±0.71
3.11±0.62
5.30±0.47
5.29±0.36
3.10±0.35
3.09±0.37
4.64±0.35
4.59±0.32

P-Value
0.76
0.90
0.81
0.15
0.24
0.55
0.97
0.49

Figure 1. IL-6 Gene Expression
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Figure 2. IL-8 Gene Expression
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Weight Status Differences
To assess the impact that weight status has on PBMC response to lipid
oversupply, lean AA and CA women were collapsed into one group (lean) and the obese
AA and CA women were collapsed into one group (obese). In the post-shake, lipidtreated condition IL-6 gene expression was significantly lower among obese women
(lean- 3.05±0.56 vs. obese- 2.48±0.50; p=0.04) (Figure 3 Panel A). Post-shake, the
expression of IL-8 significantly increased in both the control (pre- 5.32±0.28 vs. post5.60±0.27; p=0.04) and lipid (pre- 5.31±0.33 vs. post- 5.58±0.20; p=0.05) conditions in
lean women only (Figure 4); this likely drove the significant increase in IL-8 gene
expression seen among all subjects (Figure 2). Additionally, post-shake, the expression of
IL-8 was significantly lower in the lipid (lean- 5.63±0.27 vs. obese- 5.31±0.27; p=0.02)
condition in obese women compared to the lean (Figure 3 Panel B).
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Figure 3. Gene Expression in Lipid-Treated Cultures of Obese Women

3 .5

*
3 .0

*
2 .5

s

n

e

0

O

L

b

e

e

a

IL - 6 R e la tiv e E x p r e s s io n (d d C t)

P a n e l A IL - 6 G e n e E x p r e s s io n

*
5 .5

*

5 .0

s

n

e

0

O

L

b

e

e

a

IL - 8 R e la tiv e E x p r e s s io n (d d C t)

P a n e l B IL - 8 G e n e E x p r e s s io n

P re S h a k e

P ost S hake

Panel A note: * represents a significant decrease in obese women when compared
to lean women, p=0.04. Panel B Note: * represents a significant decrease in obese women
when compared to lean women, p=0.02.
32

Figure 4. IL-8 Gene Expression in Lean Women
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Chapter 5. Discussion
This is the first study to describe an examination of PBMC response to lipid
oversupply in vivo (in response to ingestion of a high fat shake) and in vitro (in response
to culturing PBMCs in media supplemented with 250uM oleate: palmiate) among
women. The purpose of the study was to determine the impact that ethnicity and/or
weight status has on PBMC response to lipid oversupply in terms of the expression of
genes that are important in the immune response (inflammation) and metabolism. Our
results indicate that the (in vivo) consumption of a high fat shake significantly impacts
the expression of IL-6 and IL-8 genes expression profiles (Figure 1 and 2) and that
differential expression patterns for IL-6 and IL-8 exist when the impact of ethnicity
and/or weight status are considered.
IL-6, synthesized by adipose tissue, endothelial cells, macrophages, and
lymphocytes, plays a vital role in multiple systems and processes, including bone
metabolism, inflammation, and acute phase reactions; while regulating energy
homeostasis and inflammation (Rodriguez-Hernandez et al., 2013). In the present study,
we found a decreased gene expression of IL-6 after the ingestion of a high fat shake in
the lipid-treated condition among AA (Figure 1 Panel B). Multiple studies have reported
an increased expression of IL-6 four hours after the ingestion of a high fat meal within
adipose tissue (Dordevic et al., 2015; Kruse et al., 2015; Meneses et al., 2011; Pietraszek,
Gregersen, & Hermansen, 2011); this contradicts our findings, suggesting what is
occurring in adipose tissue does not represent what is happening systemically from
PBMCs. Our study provided an additional dynamic by revealing AA IL-6 expression to
be contrasting with previous research. One possible explanation may be that PBMCs

34

showed an additive effect to the fatty acids used in the lipid-treated culture, though
researchers are unsure of how this decreased expression of IL-6 affected the systemic
inflammatory status. One probable explanation for the decrease in IL-6 is it is acting as
an anti-inflammatory cytokine, but at the time point post-shake ingestion IL-6 was not yet
activated; this rationale may explain why we saw a decrease in the expression of IL-6
post-shake ingestion. These findings suggest that ethnic differences may be an important
consideration with examining systemic inflammatory maker response due to a lipid
overdose.
IL-8, a pro-inflammatory cytokine, is responsible for the targeted recruitment of
neutrophils (Bickel, 1993; Hammond et al., 1995); while having roles in chemotactic
migration and activation of monocytes, lymphocytes, basophils, and eosinophils at sites
of inflammation (Miller et al., 1992). The present study found that there was an increased
gene expression of IL-8 four hours after the ingestion of a high fat shake among all
women (Figure 2). Additionally, the expression of IL-8 in PBMCs isolated from lean
women was also higher after the ingestion of a high fat shake in both lipid-treated and
control conditions (Figure 4). These findings parallel with multiples studies that have
found significant increases in IL-8 post-acute high fat ingestion (Esser et al., 2013;
Myhrstad et al., 2011; van Dijk, Mensink, et al., 2012). A possible explanation for this
increased expression of IL-8 is that oleic acid, which was used in the lipid culture and the
high fat shake, poses higher gene expression changes in inflammatory genes due to
unsaturated fatty acids being more prone to oxidation; thus, may induce more oxidative
stress and as a result affect inflammatory status of PMBCs (van Dijk, Mensink, et al.,
2012).
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Additionally, we found that PBMC gene expression of IL-8 was higher in lipid
treatment culture conditions vs control culture conditions (Figure 2). Another explanation
may be that PBMCs showed an additive effect of the saturated and unsaturated fatty
acids, resulting in an increased pro-inflammatory environment, due to the higher
expression of IL-8 in a lipid-treated culture. This may be indicative of why women show
a higher prevalence in pro-inflammatory cellular environment, thus aiding to the
development of obesity, type-2 diabetes, and other inflammatory diseases.
Moreover, AA showed an elevated gene expression of IL-8 after the ingestion of a
high fat shake in the control condition when compared to CA gene expression (Figure 2
Panel A). One explanation of this increased IL-8 expression is the type of fat used in the
shake may pose higher gene expression changes in inflammatory genes due to the type of
fatty acids in the shake being more prone to oxidation; thus, may induce more oxidative
stress and as a result affect inflammatory status of PMBCs (van Dijk, Mensink, et al.,
2012). This increased PBMC expression of IL-8 supports previous speculation that AA
have an increased pro-inflammatory cellular environment (Park & Kang, 2013) aiding in
an increased disease risk (Taylor et al., 2008) and predominance of cardiovascular risk,
obesity, high cholesterol, and hypertension (Malayala & Raza, 201).
PBMCs from obese women expressed a lower level of IL-6 and IL-8 after the
ingestion of high fat shake in the lipid-treated condition, when compared to lean women
(Figure 3). These findings suggest lean women’s PBMC response may be more sensitive
to an acute dietary stimulus or may be more sensitive to lipid post-shake ingestion due to
changes being seen in lipid-treated culture conditions. It is notable that researchers found
no shake effect on obese women’s IL-6 or IL-8 gene expression. A similar study found
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that there is no high fat meal effect for the expression of IL-8 in overweight and obese
men (Teng, Chang, Chang, & Nesaretnam, 2014). These findings, along with other IL-8
expression pattern findings of this study, suggest that IL-8 could be involved with the
development of obesity related disorders (Herder et al., 2005).
A major limitation of our study was the small sample size which could affect the
power, thus not being able to detect some statistical differences. Another limitation was
that researchers did not know the specific fatty acid makeup of the high fat shake given to
subjects. If researchers knew the specific types of fats within the shake, this could have
help developed a greater rationale for why some of the inflammatory markers were
significantly changed. Lastly, researchers did not stimulate PBMCs while in culture. This
lack of stimulation could have prevented researchers from elucidating specific gene
expression changes due to the time of PBMC culture.
This study includes many strengths that have not been previously examined.
Specifically, PBMC inflammatory gene expression response among AA and CA women
has not been fully developed. This study aids in the knowledge of how AA women
response to an acute high fat shake and compares them to CA women. Additionally, this
study divides all women into weight status categories of obese and lean. These findings
can aid in the explanation of how obesity is effected by a high fat overload, thus
explaining how the inflammatory status of these individuals is affected. Specifically, the
elevated expression of the pro-inflammatory cytokine IL-8 can further explain why
women, particularly AA women, are at higher prevalence for metabolic/ inflammatory
disease. Researchers speculate the elevated expression of IL-8, seen in this study, aids to
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chronic pro-inflammatory status of these individuals which results in higher likelihood of
developing these inflammatory diseases (Park & Kang, 2013).
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Chapter 6. Conclusion
In this study, we demonstrated that PBMCs express unique gene changes in
different ethnic and weight status subsets of women. The purpose of this study was to
examine PBMC response to lipid oversupply in vivo (in response to consuming a high fat
meal) and in vitro (in response to culturing PBMCs in media supplemented with lipid)
among AA and CA women. The secondary purpose was to determine the impact that
weight status may have on this response. Among all women, there was a trend for a
decreased expression of IL-6, post-shake ingestion, in the lipid-treated culture condition.
Additionally, all women showed a significant increase in IL-8 expression, post-shake
ingestion, in both the control and lipid-treated culture conditions. AA women showed a
significant decrease in the expression of IL-6, post-shake ingestion, in the lipid-treated
culture condition. While AA women showed a significantly higher expression of IL-8,
post-shake ingestion in the control culture condition, when compared to CA women.
Obese women showed a significantly lower expression of IL-6 and IL-8, post-shake
ingestion in the lipid-treated culture condition, when compared to lean women. While
Lean women showed a significant increase in the expression of IL-8, post-shake
ingestion, in both the control and lipid-treated culture conditions. Our data revealed
specific gene expression differences of PBMC in regards to IL-6 and IL-8, with time,
ethnicity, and weight status effects. In summary, our study showed that PBMCs are
sensitive enough to reveal the inflammatory status of women in response to the ingestion
of an acute high fat shake, with specific gene expression differences noted among women
of different ethnicities (AA vs CA) and weight statuses (lean vs obese). While this PBMC
response seen in our study necessitates a greater examination, PBMC response to a high
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fat shake elicits an inflammatory response which researchers speculate that this response
may lead to chronic inflammatory disease due possible chronic nature of this
inflammatory status.
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Appendix B
Adapted from Pretest meals created by Registered Dieticians at the Washington
University School of Medicine’s Metabolic Kitchen as part of the Clinical Research Unit.

Pretest Meals
Lean (800 calories), over weight (1000 calories), and obese (1200 calories) women
Lean (800 calories) Meal:
In order to prepare for the testing on the WKU, we would like to ask for you to follow a specific
diet for the dinner the night before you come into the Lab.
Begin your dinner meal around 6 pm, have an evening snack around 9 pm, and then only drink
water after that.
Eat all of the food on the menu to get adequate amounts of food.
Avoid alcohol for 24 hours before coming in for the testing.
Prepare the meals as stated without adding anything extra other that herbs or spices, including salt
and pepper
Do not consume any caffeine or chocolate
Dinner:
3 ounces (about the size of a deck of cards) of baked, broiled or grilled chicken, beef, pork, fish
or tofu
1 medium baked potato, sweet potato or equal amount of mashed potatoes, cooked pasta or rice
1 ounce sour cream or ¼ cup of gravy or sauce (like Alfredo) for potato, pasta or rice
½ cup carrots, green beans, asparagus, or other non-starchy vegetable
1 dinner roll, slice of bread or equal amount of pita, naan or corn bread
2 teaspoons margarine or butter
½ cup grapes or one small peach, orange, apple or other desired fruit
½ cup ice cream, sherbet or frozen yogurt or 1 serving vanilla wafers or shortbread cookies
½ cup apple or other fruit juice
Evening Snack- to be eaten at 9 pm:
3 graham cracker squares
1 cup 2% milk
Or
½ peanut butter and jelly sandwich
After that, do not eat or drink anything, except water, until after the health professional tells you
may eat at the Exercise Laboratory.
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Overweight (1000 calories) Meal:
In order to prepare for the testing at the Medical Center, we would like to ask for you to
follow a specific diet for the dinner the night before you come to visit us.
Begin your dinner meal around 6 pm, have an evening snack around 9 pm, and then only
drink water after that.
Eat all of the food on the menu to get adequate amounts of food.
Avoid alcohol for 24 hours before coming in for the testing.
Prepare the meals as stated without adding anything extra other that herbs or spices,
including salt and pepper
Do not consume any caffeine or chocolate
Dinner:
3 ounces (about the size of a deck of cards) of baked, broiled or grilled chicken, beef,
pork, fish or tofu
1 baked potato, sweet potato or equal amount of mashed potatoes, cooked pasta or rice
1.5-ounce sour cream or ¼ cup of gravy or sauce (like Alfredo) for potato, pasta or rice
¾ cup carrots, green beans, asparagus, or other non-starchy vegetable
1.5 dinner roll, slice of bread or equal amount of pita, naan or corn bread
1.5 teaspoons margarine or butter
¾ cup grapes or one small peach, orange, apple or other desired fruit
½ cup ice cream, sherbet or frozen yogurt or 1 serving vanilla wafers or shortbread
cookies
¾ cup apple or other fruit juice
Evening Snack- to be eaten at 9 pm:
3 graham cracker squares
1 cup 2% milk
Or
½ peanut butter and jelly sandwich
After that, do not eat or drink anything, except water, until after your nurse tells you may eat at
the Exercise Laboratory.
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Obese (1200 calories) Meal:
In order to prepare for the testing at WKU, we would like to ask for you to follow a specific diet
for the dinner the night before you come into the Lab.
Begin your dinner meal around 6 pm, eat your evening snack around 9 pm, and then drink water
only after that.
Eat all of the food on the menu to get adequate amounts of food.
Avoid alcohol for 24 hours before coming in for the testing.
Prepare the meals as stated without adding anything extra other that herbs or spices, including salt
and pepper
Do not consume any caffeine or chocolate
Dinner- to be eaten around 6 pm:
3 ounces (about the size of a deck of cards) of baked, broiled or grilled chicken, turkey, beef,
pork, fish or tofu
1 large baked potato, sweet potato or equal amount of mashed potatoes, cooked pasta or rice
2 ounces sour cream or ½ cup of gravy or sauce (like Alfredo) for potato, pasta or rice
1 cup carrots, green beans, asparagus, or other non-starchy vegetable
2 dinner rolls, 2 slices of bread or equal amounts of pita, naan or corn bread
1 tablespoon margarine or butter
1 cup grapes or one large peach, orange, apple or other desired fruit
1 slice cheese or small carton of yogurt
½ cup ice cream, sherbet or frozen yogurt or 1 serving vanilla wafers or shortbread cookies
1 cup of skim or low fat milk
Evening Snack- to be eaten at 9 pm:
3 graham cracker squares
1 cup 2% milk
Or
½ peanut butter and jelly sandwich
After that, do not eat or drink anything, except water, until after your nurse tells you may eat at
the Exercise Laboratory.
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